United States, 15th May 2026 – Evistia has confirmed a strategic investment in Quantova’s US entity, formalizing its participation in the Quantova ecosystem through an equity position tied to the company’s broader infrastructure development efforts. The investment centers around Quantova’s…

CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, including both blood…

Back to top